Biopharma Daily Stock Updates - 12/28/20

$XBI $146.46 (-2.37%) 📉


COVID-19:

$ARCT (-5.82%) - Approval to proceed with phase 2 study.

https://ir.arcturusrx.com/news-releases/news-release-details/arcturus-therapeutics-received-approval-singapore-health


$NVAX (-9.66%) - Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico

https://ir.novavax.com/news-releases/news-release-details/novavax-announces-initiation-prevent-19-pivotal-phase-3-efficacy


PIPELINE:

$CARA (+0%) - Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus

http://ir.caratherapeutics.com/news-releases/news-release-details/cara-therapeutics-submits-new-drug-application-us-food-and-drug


$HGEN (-21.14%) - Humanigen Secures U.S. Patent for Lenzilumab in Preventing Cytokine Storm and Neurotoxicity Related to CAR-T Cell Therapy

https://www.humanigen.com/press/Humanigen-Secures-U.S.-Patent-for-Lenzilumab-in-Preventing-Cytokine-Storm-and-Neurotoxicity-Related-to-CAR-T-Cell-Therapy?utm_campaign=8a964cc5-d8fb-47f3-a1f7-59fc84aa5452&utm_source=so&utm_medium=mail&cid=423c19cf-c09b-4e8a-9d0b-12cc9a1503cd

$MYOV (+20.22%) - Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health

https://investors.myovant.com/news-releases/news-release-details/myovant-sciences-and-pfizer-announce-collaboration-develop-and


FINANCIAL:

$ARVN (+1.38%) - Underwriter's options exercised post data and raise.

https://ir.arvinas.com/news-releases/news-release-details/arvinas-inc-announces-exercise-underwriters-option-purchase

0 comments